Sense Biodetection: Funding, Investors & Team (Oct 2026)
Sense Biodetection Limited is a molecular diagnostics company focused on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology.
Sense Biodetection has raised $65.0M across 2 funding rounds on record, the most recent a Series B of $15.0M announced in Nov 2021.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Sense Biodetection Company Profile and Key Stats
Latest funding round on record: Nov 2021.
Sense Biodetection Funding Rounds
Sense Biodetection raised $50.0M in a Series B announced in Apr 2021.
7 months later, a Series B of $15.0M was announced in Nov 2021.
Sense Biodetection Founders and Leadership Team
Contact details for the Sense Biodetection team: 1 of 1 has an email address on file.
Start 14-day free trial →Sense Biodetection Funding Compared to Other Health Care Startups
Sense Biodetection's latest round of $15.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sense Biodetection in Health Care and Abingdon
Companies Similar to Sense Biodetection
We are pioneering the use of semiconductor technology for next-generation neural implants. Our mission is to…
52 North Health intends to further develop medical services with a clinical gadget that utilizes man-made…
SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost…
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Sense Biodetection Funding FAQs
What does Sense Biodetection do?
Sense Biodetection Limited is a molecular diagnostics company focused on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology.
How much funding has Sense Biodetection raised?
Sense Biodetection has raised $65.0M across 2 rounds on record. The most recent is a Series B of $15.0M announced in Nov 2021.
When did Sense Biodetection last raise funding?
Sense Biodetection's most recent funding round on record is a Series B of $15.0M, announced in Nov 2021.
Who is the CEO of Sense Biodetection?
Harry lamble is listed as CEO at Sense Biodetection.
Where is Sense Biodetection headquartered?
Sense Biodetection is based in Abingdon, Oxfordshire, United Kingdom.
How many employees does Sense Biodetection have?
Sense Biodetection is in the 51-100 employee band.
How does Sense Biodetection's funding compare to other Health Care startups?
Sense Biodetection's latest round of $15.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Sense Biodetection Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sense Biodetection is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.